Dr. Lily Brown is an assistant professor of psychology in the Department of Psychiatry at the University of Pennsylvania in the Center for the Treatment and Study of Anxiety. Dr. Brown received her PhD at the University of California, Los Angeles (UCLA) under the mentorship of Dr. Michelle Craske. During her time at UCLA, Dr. Brown was the recipient of the National Science Foundation Graduate Research Fellowship, the APA Dissertation Award, and several university grants. While a graduate student, Lily served as psychology extern and chief psychology extern at Harbor-UCLA Medical Center’s Adult Outpatient Clinic under the direction of Dr. Lynn McFarr. She completed her pre-doctoral internship at Brown University under the mentorship of Dr. Michael Armey where she was awarded a Brown Internship Research Grant. Dr. Brown is the Principal Investigator (PI) on a study of implementing physical health assessment into cognitive behavior therapy (CBT) for anxiety. In addition, Dr. Brown is a co-investigator on a randomized controlled trial comparing standard prolonged exposure therapy (PE) for posttraumatic stress disorder (PTSD) to a more abbreviated protocol in active duty military personnel. Dr. Brown also coordinates a parallel trial with similar aims in civilian outpatients. She is a site-PI and co-investigator on a trial measuring physiological responses to in vivo and imaginal exposure exercises in civilians receiving PE. She coordinates the collection and analysis of physiological data as part of this trial. Dr. Brown serves as a PE consultant on a randomized controlled trial comparing two implementation strategies for PE in active duty military personnel clinicians. Finally, Dr. Brown is the co-principal investigator on a study about implementing physical health outcomes monitoring in patients completing evidence-based practices for anxiety, including PE.
Dr. Brown’s research and clinical interests are in the development and testing of evidence-based treatments for anxiety and trauma-based disorders, particularly in those with high suicide risk. She is interested in disseminating evidence-based practice into the community, and in further developing treatments for patients with anxiety at high risk for suicide.